Clinical characteristics and presence of prolactinoma in women with hyperprolactinemia

被引:0
|
作者
Alberto Lopez-Clavijo, Carlos [1 ,2 ,3 ,4 ]
Esteban Gaviria-Maya, Juan [5 ]
Eduardo Henao-Florez, Rodrigo [2 ]
Leandro Piedrahita-Gutierrez, Dany [3 ,6 ]
机构
[1] InSer Pereira, Pereira, Colombia
[2] Univ Caldas, Ginecol & Obstet, Manizales, Colombia
[3] Fdn Univ Autonoma Amer, Medellin, Colombia
[4] Univ Tecnol Pereira, Biol Mol & Biotecnol, Pereira, Colombia
[5] Univ Caldas, Manizales, Colombia
[6] InSer Pereira, Endocrinol Reprod Humana & Infertilidad, Pereira, Colombia
关键词
Amenorrhea; Galactorrhea; Hyperprolactinemia; Infertility; Magnetic Resonance Imaging; Prolactin; Prolactinoma;
D O I
10.17533/udea.iatreia.v29n3a04
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To clinically characterize women with hyperprolactinemia at InSer Pereira (Colombia) and to determine the prevalence of prolactinoma. Methods: Retrospective description of 45 patients with hyperprolactinemia, and contrasted pituitary magnetic resonance (MR), between January 2008 and July 2013. Clinical manifestations, etiology, serum prolactin level, and MR findings were included. Results: The most frequent clinical manifestations were: infertility, galactorrhea, oligomenorrhea. There were 26 cases of prolactinoma (57.8 %), and 12 of idiopathic hyperprolactinemia (26.6 %). Out of the 26 prolactinomas, 23 were microadenomas (average size 5.1 mm; SD +/- 3.2 mm). Average serum prolactin level was 74.05 ng/mL (SD +/- 13.33 ng/mL). 78 % of patients with prolactinoma had serum prolactin level under 70.0 ng/mL. No significant association was found between serum prolactin level and the presence of prolactinoma. Conclusion: Prolactinomas are the main cause of hyperprolactinemia and they are found mostly with slight rise of serum prolactin. Pituitary MRI is recommended in patients with hyperprolactinemia, regardless of their prolactin level.
引用
收藏
页码:292 / 300
页数:9
相关论文
共 50 条
  • [1] HYPERPROLACTINEMIA - WHEN IS A PROLACTINOMA NOT A PROLACTINOMA
    不详
    LANCET, 1987, 2 (8566): : 1002 - 1004
  • [2] Clinical guidelines for diagnosis and treatment of prolactinoma and hyperprolactinemia
    Halperin Rabinovich, Irene
    Camara Gomez, Rosa
    Garcia Mouriz, Marta
    Ollero Garcia-Agullo, Dolores
    ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (06): : 308 - 319
  • [3] CRANIOPHARYNGIOMA WITH HYPERPROLACTINEMIA DUE TO A PROLACTINOMA
    WHEATLEY, T
    CLARK, JDA
    STEWART, S
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1986, 49 (11): : 1305 - 1307
  • [4] CRANIOPHARYNGIOMA WITH HYPERPROLACTINEMIA DUE TO A PROLACTINOMA
    STEWART, S
    CLARK, JDA
    WHEATLEY, T
    JOURNAL OF ENDOCRINOLOGY, 1986, 108 : 262 - 262
  • [5] A RARE CASE OF A GIANT PROLACTINOMA PRESENTING WITHOUT CLINICAL SYMPTOMS OF HYPERPROLACTINEMIA
    McNiven, Mallory
    Vieira, Flavio
    Mehta, Vivek
    Waldner, Richelle
    Haqq, Andrea
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 98 - 99
  • [6] RECURRENCE OF HYPERPROLACTINEMIA AFTER SELECTIVE TRANS-SPHENOIDAL ADENOMECTOMY IN WOMEN WITH PROLACTINOMA
    SERRI, O
    RASIO, E
    BEAUREGARD, H
    HARDY, J
    SOMMA, M
    NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (05): : 280 - 283
  • [7] A Case Report and Review of Hyperprolactinemia that is not Prolactinoma
    Salehi, Fateme
    Doglietto, Francesca
    Ridout, Rowena
    Gentili, Fred
    Asa, Sylvia
    Zadeh, Gelareh
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2011, 38 (04) : 652 - 655
  • [8] PROLACTINOMA IN WOMEN - CLINICAL AND BIOLOGICAL STUDY
    BEAUREGARD, H
    VANCAMPENHOUT, J
    RASIO, E
    SOMMA, M
    NEUROCHIRURGIE, 1981, 27 : 29 - 35
  • [9] Prolactinoma: Clinical Characteristics, Management and Outcome
    Irfan, Hira
    Shafiq, Waqas
    Siddiqi, Ahmed Imran
    Ashfaq, Sara
    Attaullah, Sadaf
    Alvi, Asim Munir
    Khan, Sardar Ali
    Abu Bakar, Muhammad
    Azmat, Umal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [10] Quetiapine treatment in neuroleptic induced hyperprolactinemia and prolactinoma
    Bestepe, EE
    Soysal, H
    Belene, A
    Ozden, SY
    Ozen, M
    Turkmenoglu, M
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S245 - S246